<?xml version="1.0" encoding="UTF-8"?>
<!-- This sitemap was dynamically generated on April 4, 2026 at 12:14 AM by All in One SEO v4.9.2 - the original SEO plugin for WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://inpharmedia.com/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Inpharmedia | Online Learning Platform</title>
		<link><![CDATA[https://inpharmedia.com]]></link>
		<description><![CDATA[Inpharmedia | Online Learning Platform]]></description>
		<lastBuildDate><![CDATA[Wed, 19 Nov 2025 06:05:20 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://inpharmedia.com/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://inpharmedia.com/post-a-job/]]></guid>
			<link><![CDATA[https://inpharmedia.com/post-a-job/]]></link>
			<title>Post a Job</title>
			<pubDate><![CDATA[Wed, 19 Nov 2025 06:05:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/job-dashboard/]]></guid>
			<link><![CDATA[https://inpharmedia.com/job-dashboard/]]></link>
			<title>Job Dashboard</title>
			<pubDate><![CDATA[Wed, 19 Nov 2025 06:05:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/jobs/]]></guid>
			<link><![CDATA[https://inpharmedia.com/jobs/]]></link>
			<title>Jobs</title>
			<pubDate><![CDATA[Wed, 19 Nov 2025 06:05:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/different-types-of-applications-in-usa/]]></guid>
			<link><![CDATA[https://inpharmedia.com/different-types-of-applications-in-usa/]]></link>
			<title>Types of Applications to register and market  a new Drug and Biologic  in U.S</title>
			<pubDate><![CDATA[Wed, 08 Jan 2025 12:55:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/fda-inspection-forms-guide/]]></guid>
			<link><![CDATA[https://inpharmedia.com/fda-inspection-forms-guide/]]></link>
			<title>FDA Inspection Forms Guide: Understanding Form 482, Form 483, Form 484, and Key Enforcement Actions</title>
			<pubDate><![CDATA[Tue, 11 Nov 2025 06:37:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/fdas-published-a-revised-draft-guidance-on-obesity-and-overweight-a-new-era-for-weight-reduction-therapies/]]></guid>
			<link><![CDATA[https://inpharmedia.com/fdas-published-a-revised-draft-guidance-on-obesity-and-overweight-a-new-era-for-weight-reduction-therapies/]]></link>
			<title>FDA&#8217;s Published a revised draft guidance on Obesity and Overweight – A New Era for Weight Reduction Therapies</title>
			<pubDate><![CDATA[Tue, 04 Mar 2025 17:16:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/ctd-structure/]]></guid>
			<link><![CDATA[https://inpharmedia.com/ctd-structure/]]></link>
			<title>Mastering the CTD: Harmonized Regulatory Data Submissions</title>
			<pubDate><![CDATA[Thu, 30 Jan 2025 15:37:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/how-to-submit-orphan-drug-designation-request-fda/]]></guid>
			<link><![CDATA[https://inpharmedia.com/how-to-submit-orphan-drug-designation-request-fda/]]></link>
			<title>How to Submit an Orphan Drug Designation Request to FDA</title>
			<pubDate><![CDATA[Sat, 25 Oct 2025 09:42:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/intellectual-property-rights-ipr-review/]]></guid>
			<link><![CDATA[https://inpharmedia.com/intellectual-property-rights-ipr-review/]]></link>
			<title>Intellectual Property Rights (IPR) in the Pharmaceutical Industry: A Comprehensive Review</title>
			<pubDate><![CDATA[Sat, 22 Feb 2025 07:53:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/titanium-dioxide-in-pharmaceuticals-safety-regulation-and-future/]]></guid>
			<link><![CDATA[https://inpharmedia.com/titanium-dioxide-in-pharmaceuticals-safety-regulation-and-future/]]></link>
			<title>Titanium Dioxide in Pharmaceuticals: Balancing Safety, Science, and Supply Chain Reality</title>
			<pubDate><![CDATA[Mon, 10 Nov 2025 05:37:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/fda-new-drug-approvals-in-2024-insights-into-latest-trends-milestones-and-innovations/]]></guid>
			<link><![CDATA[https://inpharmedia.com/fda-new-drug-approvals-in-2024-insights-into-latest-trends-milestones-and-innovations/]]></link>
			<title>FDA New Drug Approvals in 2024: Insights into Latest Trends, Milestones, and Innovations</title>
			<pubDate><![CDATA[Mon, 06 Jan 2025 03:28:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/impurities-classification-thresholds-limits-specification-with-rtr-considerations-in-apis-and-finished-products/]]></guid>
			<link><![CDATA[https://inpharmedia.com/impurities-classification-thresholds-limits-specification-with-rtr-considerations-in-apis-and-finished-products/]]></link>
			<title>Impurities – Classification, Thresholds Limits, Specification with RTR Considerations in APIs and Finished Products</title>
			<pubDate><![CDATA[Sat, 07 Dec 2024 18:49:53 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/residual-solvents-classification-assessment/]]></guid>
			<link><![CDATA[https://inpharmedia.com/residual-solvents-classification-assessment/]]></link>
			<title>Residual Solvents – Basics, Classification and Assessment</title>
			<pubDate><![CDATA[Sat, 07 Dec 2024 18:49:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/stability-data-requirements-for-a-marketing-authorization-application/]]></guid>
			<link><![CDATA[https://inpharmedia.com/stability-data-requirements-for-a-marketing-authorization-application/]]></link>
			<title>Stability data Requirements for a Marketing Authorization Application</title>
			<pubDate><![CDATA[Sat, 07 Dec 2024 18:49:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/fda-recommendations-topical-ophthalmics/]]></guid>
			<link><![CDATA[https://inpharmedia.com/fda-recommendations-topical-ophthalmics/]]></link>
			<title>FDA recommendations on Quality Considerations for Topical Ophthalmic Drug Products</title>
			<pubDate><![CDATA[Sat, 07 Dec 2024 18:49:19 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/us-fda-databases-a-prime-tool-for-regulatory-intelligence/]]></guid>
			<link><![CDATA[https://inpharmedia.com/us-fda-databases-a-prime-tool-for-regulatory-intelligence/]]></link>
			<title>US FDA DATABASES &#8211; A PRIME TOOL FOR REGULATORY INTELLIGENCE</title>
			<pubDate><![CDATA[Sat, 07 Dec 2024 18:49:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/fda-approved-ogsiveo-as-the-first-and-only-treatment-for-desmoid-tumours/]]></guid>
			<link><![CDATA[https://inpharmedia.com/fda-approved-ogsiveo-as-the-first-and-only-treatment-for-desmoid-tumours/]]></link>
			<title>FDA Approved OGSIVEO as the FIRST and ONLY treatment for Desmoid Tumours</title>
			<pubDate><![CDATA[Sat, 07 Dec 2024 18:46:13 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/bacterial-endotoxin-test/]]></guid>
			<link><![CDATA[https://inpharmedia.com/bacterial-endotoxin-test/]]></link>
			<title>Understanding the Bacterial Endotoxin Test: A Critical Step for Ensuring Sterile Product Safety</title>
			<pubDate><![CDATA[Sat, 07 Dec 2024 18:46:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/revising-anda-labeling-rld-labeling/]]></guid>
			<link><![CDATA[https://inpharmedia.com/revising-anda-labeling-rld-labeling/]]></link>
			<title>FDA Guidance &#8211; Revising ANDA Labeling Following Revision of the RLD Labeling</title>
			<pubDate><![CDATA[Sat, 07 Dec 2024 18:45:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-january-2022/]]></guid>
			<link><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-january-2022/]]></link>
			<title>US FDA Guidances Published in January 2022</title>
			<pubDate><![CDATA[Sat, 07 Dec 2024 18:45:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/types-of-market-exclusivities-and-implications-on-forfeiture/]]></guid>
			<link><![CDATA[https://inpharmedia.com/types-of-market-exclusivities-and-implications-on-forfeiture/]]></link>
			<title>Types of Market Exclusivities and Implications on Forfeiture</title>
			<pubDate><![CDATA[Sat, 07 Dec 2024 18:45:20 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/types-of-exclusivities-and-incentives-offered-by-different-health-authorities/]]></guid>
			<link><![CDATA[https://inpharmedia.com/types-of-exclusivities-and-incentives-offered-by-different-health-authorities/]]></link>
			<title>Types of Exclusivities and Incentive Periods by Global Health Authorities</title>
			<pubDate><![CDATA[Sat, 07 Dec 2024 18:45:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/the-hatch-waxman-act-balancing-the-drug-patents-and-generic-entry/]]></guid>
			<link><![CDATA[https://inpharmedia.com/the-hatch-waxman-act-balancing-the-drug-patents-and-generic-entry/]]></link>
			<title>The Hatch-Waxman Act : Balancing Drug Patents and Generic Entry</title>
			<pubDate><![CDATA[Sat, 07 Dec 2024 18:45:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/blog/]]></guid>
			<link><![CDATA[https://inpharmedia.com/blog/]]></link>
			<title>Blog</title>
			<pubDate><![CDATA[Wed, 29 Nov 2023 16:50:48 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/privacy-policy/]]></guid>
			<link><![CDATA[https://inpharmedia.com/privacy-policy/]]></link>
			<title>Privacy Policy</title>
			<pubDate><![CDATA[Wed, 29 Nov 2023 15:29:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/gdpr-privacy/]]></guid>
			<link><![CDATA[https://inpharmedia.com/gdpr-privacy/]]></link>
			<title>GDPR Privacy</title>
			<pubDate><![CDATA[Wed, 29 Nov 2023 15:25:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/terms-and-conditions/]]></guid>
			<link><![CDATA[https://inpharmedia.com/terms-and-conditions/]]></link>
			<title>Terms and Conditions</title>
			<pubDate><![CDATA[Wed, 29 Nov 2023 15:21:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/contact/]]></guid>
			<link><![CDATA[https://inpharmedia.com/contact/]]></link>
			<title>Contact</title>
			<pubDate><![CDATA[Sun, 26 Nov 2023 22:48:34 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/fda-novel-drug-approvals-in-january-2022/]]></guid>
			<link><![CDATA[https://inpharmedia.com/fda-novel-drug-approvals-in-january-2022/]]></link>
			<title>FDA Novel Drug Approvals in January 2022</title>
			<pubDate><![CDATA[Sun, 26 Nov 2023 17:09:09 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/fda-novel-drug-approvals-in-january-2023/]]></guid>
			<link><![CDATA[https://inpharmedia.com/fda-novel-drug-approvals-in-january-2023/]]></link>
			<title>FDA Novel Drug Approvals in January 2023</title>
			<pubDate><![CDATA[Sun, 26 Nov 2023 16:39:43 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/refuse-to-receive-standards-key-insights-for-successful-anda-submissions/]]></guid>
			<link><![CDATA[https://inpharmedia.com/refuse-to-receive-standards-key-insights-for-successful-anda-submissions/]]></link>
			<title>Navigating Refuse to Receive (RTR) Standards: Key Insights for Successful ANDA Submissions</title>
			<pubDate><![CDATA[Sat, 07 Dec 2024 17:31:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/unlock-product-development-with-the-inactive-ingredient-database/]]></guid>
			<link><![CDATA[https://inpharmedia.com/unlock-product-development-with-the-inactive-ingredient-database/]]></link>
			<title>Unlock Product Development with the Inactive Ingredient Database (IIG)</title>
			<pubDate><![CDATA[Sat, 07 Dec 2024 17:14:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/drug-development-lifecycle-from-discovery-to-market-approval/]]></guid>
			<link><![CDATA[https://inpharmedia.com/drug-development-lifecycle-from-discovery-to-market-approval/]]></link>
			<title>Complete Guide to the Drug Development Lifecycle: From Discovery to Market Approval</title>
			<pubDate><![CDATA[Sat, 07 Dec 2024 17:13:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-march-2022/]]></guid>
			<link><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-march-2022/]]></link>
			<title>US FDA Guidances Published in March 2022</title>
			<pubDate><![CDATA[Fri, 24 Nov 2023 18:21:01 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-july-2022/]]></guid>
			<link><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-july-2022/]]></link>
			<title>US FDA Guidances Published in July 2022</title>
			<pubDate><![CDATA[Fri, 24 Nov 2023 18:14:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-august-2022/]]></guid>
			<link><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-august-2022/]]></link>
			<title>US FDA Guidances Published in August 2022</title>
			<pubDate><![CDATA[Fri, 24 Nov 2023 18:07:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-january-2023/]]></guid>
			<link><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-january-2023/]]></link>
			<title>US FDA Guidances Published in January 2023</title>
			<pubDate><![CDATA[Fri, 24 Nov 2023 17:52:23 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-september-2022/]]></guid>
			<link><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-september-2022/]]></link>
			<title>US FDA Guidances Published in September 2022</title>
			<pubDate><![CDATA[Fri, 24 Nov 2023 17:45:10 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-october-2022/]]></guid>
			<link><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-october-2022/]]></link>
			<title>US FDA Guidances Published in October 2022</title>
			<pubDate><![CDATA[Fri, 24 Nov 2023 17:33:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-may-2022/]]></guid>
			<link><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-may-2022/]]></link>
			<title>US FDA Guidances Published in May 2022</title>
			<pubDate><![CDATA[Fri, 24 Nov 2023 17:20:31 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-november-2022/]]></guid>
			<link><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-november-2022/]]></link>
			<title>US FDA Guidances Published in November 2022</title>
			<pubDate><![CDATA[Fri, 24 Nov 2023 17:09:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-december-2022/]]></guid>
			<link><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-december-2022/]]></link>
			<title>US FDA Guidances Published in December 2022</title>
			<pubDate><![CDATA[Fri, 24 Nov 2023 16:54:21 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-june-2022/]]></guid>
			<link><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-june-2022/]]></link>
			<title>US FDA Guidances Published in June 2022</title>
			<pubDate><![CDATA[Fri, 24 Nov 2023 16:39:42 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-april-2022/]]></guid>
			<link><![CDATA[https://inpharmedia.com/us-fda-guidances-published-in-april-2022/]]></link>
			<title>US FDA Guidances Published in April 2022</title>
			<pubDate><![CDATA[Fri, 24 Nov 2023 16:31:52 +0000]]></pubDate>
		</item>
				</channel>
</rss>
